Hanmi Pharm Q3 net income down 69.1% to $10.6 mil.
Hanmi Pharm on Tuesday reported a third-quarter net income of 14 billion won ($10.6 million), down 69.1 percent from a year earlier. The Korean pharmaceutical company said in a regulatory filing that operating profit for the July-September period fell 31.3 percent on-year to 37.8 billion won. Revenue increased 4.2 percent to 377.4 billion won. The earnings failed to meet market expectations. The…
We haven't written up this one. The Korea Times has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Hanmi Pharm Q3 net income down 69.1% to $10.6 mil. koreatimes.co.kr
